Nox2 and Nox4 mediate tumour necrosis factor-α-induced ventricular remodelling in mice.
Reactive oxygen species (ROS) and pro-inflammatory cytokines are crucial in ventricular remodelling, such as inflammation-associated myocarditis. We previously reported that tumour necrosis factor-α (TNF-α)-induced ROS in human aortic smooth muscle cells is mediated by NADPH oxidase subunit Nox4. In this study, we investigated whether TNF-α-induced ventricular remodelling was mediated by Nox2 and/or Nox4. An intravenous injection of murine TNF-α was administered to a group of mice and saline injection was administered to controls. Echocardiography was performed on days 1, 7 and 28 post-injection. Ventricular tissue was used to determine gene and protein expression of Nox2, Nox4, ANP, interleukin (IL)-1β, IL-2, IL-6, TNF-α and to measure ROS. Nox2 and Nox4 siRNA were used to determine whether or not Nox2 and Nox4 mediated TNF-α-induced ROS and upregulation of IL-1β and IL-6 in adult human cardiomyocytes. Echocardiography showed a significant increase in left ventricular end-diastolic and left ventricular end-systolic diameters, and a significant decrease in the ejection fraction and fractional shortening in mice 7 and 28 days after TNF-α injection. These two groups of mice showed a significant increase in ventricular ROS, ANP, IL-1β, IL-2, IL-6 and TNF-α proteins. Nox2 and Nox4 mRNA and protein levels were also sequentially increased. ROS was significantly decreased by inhibitors of NADPH oxidase, but not by inhibitors of other ROS production systems. Nox2 and Nox4 siRNA significantly attenuated TNF-α-induced ROS and upregulation of IL-1β and IL-6 in cardiomyocytes. Our study highlights a novel TNF-α-induced chronic ventricular remodelling mechanism mediated by sequential regulation of Nox2 and Nox4 subunits.
Research and Development Unit, National Heart Centre Singapore, Singapore. moe.kyaw.thu@nhc.com.sg
K T
KT
Moe
N O
NO
Yin
T M
TM
Naylynn
K
K
Khairunnisa
M A
MA
Wutyi
Y
Y
Gu
M S M
MS
Atan
M C
MC
Wong
T H
TH
Koh
P
P
Wong
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D015153:Blotting, Western; D002478:Cells, Cultured; D016207:Cytokines / Q000235:genetics / Q000378:metabolism; D006801:Humans; D007124:Immunoenzyme Techniques; D053583:Interleukin-1beta / Q000235:genetics / Q000378:metabolism; D015850:Interleukin-6 / Q000235:genetics / Q000378:metabolism; D008297:Male; D008562:Membrane Glycoproteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D032383:Myocytes, Cardiac / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism*; D000074662:NADPH Oxidase 2; D000074663:NADPH Oxidase 4; D019255:NADPH Oxidases / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D018384:Oxidative Stress; D012333:RNA, Messenger / Q000235:genetics; D034741:RNA, Small Interfering / Q000235:genetics; D017382:Reactive Oxygen Species / Q000378:metabolism; D060888:Real-Time Polymerase Chain Reaction; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*; D020257:Ventricular Remodeling / Q000187:drug effects*
D000975:Antioxidants; D016207:Cytokines; D053583:Interleukin-1beta; D015850:Interleukin-6; D008562:Membrane Glycoproteins; D012333:RNA, Messenger; D034741:RNA, Small Interfering; D017382:Reactive Oxygen Species; D014409:Tumor Necrosis Factor-alpha; C488842:Cybb protein, mouse; D000074662:NADPH Oxidase 2; D000074663:NADPH Oxidase 4; D019255:NADPH Oxidases; C422943:Nox4 protein, mouse
J Biol Chem. 2009 Jan 30;284(5):3058-3068
19049974
Crit Care Nurs Clin North Am. 2003 Dec;15(4):407-11
14717385
Am J Physiol. 1998 Mar;274(3):R577-95
9530222
J Leukoc Biol. 1993 Aug;54(2):171-8
7689630
Circulation. 2002 Jan 22;105(3):293-6
11804982
Am J Physiol Gastrointest Liver Physiol. 2005 Jun;288(6):G1328-38
15637179
J Neurosci. 2002 Aug 15;22(16):7006-15
12177198
Physiology (Bethesda). 2006 Aug;21:269-80
16868316
Am J Physiol Lung Cell Mol Physiol. 2004 Jan;286(1):L37-48
12807699
Philos Trans R Soc Lond B Biol Sci. 2005 Dec 29;360(1464):2327-34
16321803
Curr Eye Res. 2001 Jul;23(1):44-50
11821985
Circ Res. 2005 May 13;96(9):939-49
15890981
Eur J Cardiothorac Surg. 2005 Apr;27(4):611-6
15784359
Cardiovasc Res. 2006 May 1;70(2):384-90
16443208
Chest. 1994 Mar;105(3):897-904
8131560
Am J Physiol Heart Circ Physiol. 2009 May;296(5):H1466-83
19286953
Circ Res. 2003 Oct 31;93(9):802-5
14551238
J Cell Mol Med. 2006 Jan-Mar;10(1):231-9
16563235
Eur J Echocardiogr. 2006 Dec;7(6):411-7
16672194
J Card Fail. 1996 Sep;2(3):243-9
8891862
Am J Physiol Lung Cell Mol Physiol. 2006 Apr;290(4):L661-L673
16227320
J Am Coll Cardiol. 2000 Mar 1;35(3):537-44
10716453
Exp Biol Med (Maywood). 2007 May;232(5):622-8
17463158
Circulation. 2007 Mar 20;115(11):1398-407
17353445
Arch Dis Child. 1990 Dec;65(12):1293-4
2148666
Circulation. 1998 Apr 14;97(14):1382-91
9577950
J Am Coll Cardiol. 2000 Mar 1;35(3):569-82
10716457
Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):9997-10002
10468550
J Am Coll Cardiol. 1996 Apr;27(5):1201-6
8609343
Circ Res. 2003 Oct 17;93(8):767-75
14500337
FASEB J. 2006 May;20(7):970-2
16608872
J Histochem Cytochem. 2009 Apr;57(4):373-82
19110482
Circulation. 2004 Nov 16;110(20):3221-8
15533863
N Engl J Med. 1990 Jul 26;323(4):236-41
2195340
Circulation. 1996 Feb 15;93(4):704-11
8640999
Clin Sci (Lond). 2004 Mar;106(3):219-34
14733610
Circ Res. 2004 Jun 25;94(12):1543-53
15217919
Mech Ageing Dev. 2004 Oct-Nov;125(10-11):799-810
15541774
Hypertension. 2008 Feb;51(2):319-25
18180403
Cardiovasc Pathol. 2009 May-Jun;18(3):156-66
18402834
J Clin Endocrinol Metab. 2004 Jun;89(6):2548-56
15181022
J Card Fail. 1997 Jun;3(2):117-24
9220311
J Biol Chem. 1997 Feb 21;272(8):4836-42
9030540